Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease
© 2018, Xian et al..
ApoE4 genotype is the most prevalent and also clinically most important risk factor for late-onset Alzheimer's disease (AD). Available evidence suggests that the root cause for this increased risk is a trafficking defect at the level of the early endosome. ApoE4 differs from the most common ApoE3 isoform by a single amino acid that increases its isoelectric point and promotes unfolding of ApoE4 upon endosomal vesicle acidification. We found that pharmacological and genetic inhibition of NHE6, the primary proton leak channel in the early endosome, in rodents completely reverses the ApoE4-induced recycling block of the ApoE receptor Apoer2/Lrp8 and the AMPA- and NMDA-type glutamate receptors that are regulated by, and co-endocytosed in a complex with, Apoer2. Moreover, NHE6 inhibition restores the Reelin-mediated modulation of excitatory synapses that is impaired by ApoE4. Our findings suggest a novel potential approach for the prevention of late-onset AD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
eLife - 7(2018) vom: 30. Okt. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xian, Xunde [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.03.2019 Date Revised 04.12.2021 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.7554/eLife.40048 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM290096677 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM290096677 | ||
| 003 | DE-627 | ||
| 005 | 20231225064004.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7554/eLife.40048 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0966.xml |
| 035 | |a (DE-627)NLM290096677 | ||
| 035 | |a (NLM)30375977 | ||
| 035 | |a (PII)e40048 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Xian, Xunde |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2019 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2018, Xian et al. | ||
| 520 | |a ApoE4 genotype is the most prevalent and also clinically most important risk factor for late-onset Alzheimer's disease (AD). Available evidence suggests that the root cause for this increased risk is a trafficking defect at the level of the early endosome. ApoE4 differs from the most common ApoE3 isoform by a single amino acid that increases its isoelectric point and promotes unfolding of ApoE4 upon endosomal vesicle acidification. We found that pharmacological and genetic inhibition of NHE6, the primary proton leak channel in the early endosome, in rodents completely reverses the ApoE4-induced recycling block of the ApoE receptor Apoer2/Lrp8 and the AMPA- and NMDA-type glutamate receptors that are regulated by, and co-endocytosed in a complex with, Apoer2. Moreover, NHE6 inhibition restores the Reelin-mediated modulation of excitatory synapses that is impaired by ApoE4. Our findings suggest a novel potential approach for the prevention of late-onset AD | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a NHE | |
| 650 | 4 | |a endosome | |
| 650 | 4 | |a human | |
| 650 | 4 | |a human biology | |
| 650 | 4 | |a medicine | |
| 650 | 4 | |a mouse | |
| 650 | 4 | |a neurodegeneration | |
| 650 | 4 | |a neuroscience | |
| 650 | 4 | |a rat | |
| 650 | 4 | |a recycling | |
| 650 | 4 | |a synaptic plasticity | |
| 650 | 7 | |a Apolipoprotein E4 |2 NLM | |
| 650 | 7 | |a LDL-Receptor Related Proteins |2 NLM | |
| 650 | 7 | |a NHE6 protein, mouse |2 NLM | |
| 650 | 7 | |a Receptors, Glutamate |2 NLM | |
| 650 | 7 | |a Reelin Protein |2 NLM | |
| 650 | 7 | |a Reln protein, rat |2 NLM | |
| 650 | 7 | |a Sodium-Hydrogen Exchangers |2 NLM | |
| 650 | 7 | |a low density lipoprotein receptor-related protein 8 |2 NLM | |
| 650 | 7 | |a RELN protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a Reln protein, mouse |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 700 | 1 | |a Pohlkamp, Theresa |e verfasserin |4 aut | |
| 700 | 1 | |a Durakoglugil, Murat S |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Connie H |e verfasserin |4 aut | |
| 700 | 1 | |a Beck, Jürgen K |e verfasserin |4 aut | |
| 700 | 1 | |a Lane-Donovan, Courtney |e verfasserin |4 aut | |
| 700 | 1 | |a Plattner, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Herz, Joachim |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t eLife |d 2012 |g 7(2018) vom: 30. Okt. |w (DE-627)NLM221831460 |x 2050-084X |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2018 |g day:30 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.7554/eLife.40048 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2018 |b 30 |c 10 | ||